LENSAR, Inc. 8-K

What Happened

• LENSAR, Inc. announced on May 25, 2026 that Michael A. Rossi was appointed Interim Chief Financial Officer and principal financial officer, effective May 29, 2026. The company engaged Monomoy Advisors LLC to make Mr. Rossi available under a consulting agreement paying $375 per hour. The filing also sets LENSAR’s 2026 annual meeting of stockholders for August 4, 2026 (virtual).

Key Details

• Interim CFO: Michael A. Rossi (age 52); background includes CFO roles at Access Vascular (CFO Mar–Jul 2025; consulting CFO Apr 2024–Feb 2025), ConcertAI (Feb–Sep 2023), and Harvard Bioscience (Jul 2019–Dec 2022); B.S. in accounting and MBA from Babson College.
• Consulting terms: Company engaged Monomoy Advisors LLC; cash retainer of $375 per hour for Mr. Rossi’s services; Mr. Rossi is expected to sign LENSAR’s standard indemnification agreement.
• Annual meeting: 2026 Annual Meeting scheduled for Aug 4, 2026 (virtual); record holders of common stock and Series A Convertible Preferred as of close of business on June 10, 2026 may vote.
• Proposal/nomination deadlines: To be included in proxy under Rule 14a-8, proposals must be received by June 8, 2026; same June 8, 2026 deadline applies for bylaw advance-notice nominations and for notices required by the universal proxy rule (Rule 14a-19).

Why It Matters

• The appointment addresses LENSAR’s immediate senior finance leadership needs by bringing in an experienced turnaround and public-company finance executive on an interim, consulting basis, which could affect near-term financial oversight and reporting continuity.
• The announced annual meeting date and specified record and filing deadlines (June 8–10, 2026) are material for stockholders who wish to submit proposals, nominate directors, or vote, and set the timeline for upcoming corporate governance actions and proxy materials.